Gene activated matrix therapies - Selective Genetics
Alternative Names: non-union fracture GAM therapyLatest Information Update: 24 Oct 2021
Price :
$50 *
At a glance
- Originator Selective Genetics (CEASED); University of Michigan Medical School
- Developer Biomet; Selective Genetics (CEASED); University of Michigan Medical School
- Class
- Mechanism of Action Osteogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Non-union fracture; Osteoporosis; Spinal cord injuries
Most Recent Events
- 30 Sep 2006 Discontinued - Preclinical for Spinal cord injuries in USA (unspecified route)
- 20 Jul 2006 Discontinued - Preclinical for Osteoporosis in USA (Intralesional)
- 30 Apr 2006 Discontinued - Preclinical for Non-union fracture in USA (Intralesional)